GlassScriptPhysician profile
Eric M Traviss
NPI 1568875102
$3,177.46
in general payments reported to CMS, 2019-2025
18 companies · $298 in 2025
The $298 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $139 · 2022: $45.13 · 2023: $2,229 · 2024: $466 · 2025: $298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,751 · Food and Beverage: $1,242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,750.77 |
| Food and Beverage | $1,242.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,128.78 | 2023-2024 | Ams 700 Cxr Rte Kit |
| Teleflex LLC | $372.62 | 2021-2025 | Urolift, Barrigel |
| Janssen Biotech, INC. | $187.20 | 2022-2025 | Carvykti, Rybrevant, Erleada |
| Sumitomo Pharma America, INC. | $93.14 | 2023-2025 | Orgovyx |
| Immunitybio, INC. | $74.60 | 2024-2025 | |
| Antares Pharma, INC. | $62.28 | 2024-2025 | Xyosted |
| Medtronic, INC. | $38.31 | 2022-2023 | Interstim |
| Endo Pharmaceuticals INC. | $35.66 | 2023 | Xiaflex, Aveed |
| Tolmar, INC. | $31.22 | 2023 | |
| Urogen Pharma, INC. | $20.85 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $20.37 | 2025 | Bard Inlay Optima Ureteral Stent With Hydroglide Guidewire |
| Novartis Pharmaceuticals Corporation | $20.37 | 2023 | |
| Smith+Nephew, INC. | $17.26 | 2024 | Stravix |
| Astrazeneca Pharmaceuticals LP | $17.08 | 2024 | Lynparza |
| 180 Medical, INC. | $15.45 | 2023 | Gentlecath |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $15.39 | 2024 | |
| Convatec INC. | $13.73 | 2022 | |
| Angiodynamics, INC. | $13.15 | 2024 | Nanoknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Traviss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.